Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{204022,
        author = {Bhupendra Deelip Patil and Madhuri Bansilal Darade},
        title = {Pharmacogenomics and Personalized Medicine: Exploring the Impact of Genetic Variation on Drug Response and Personalized Treatment Plans},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {13},
        number = {1},
        pages = {1330-1332},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=204022},
        abstract = {Pharmacogenomics is an emerging field that combines pharmacology and genomics to understand how genetic variations influence individual responses to drugs. Personalized medicine aims to provide the right medication at the right dose to the right patient based on genetic makeup, environmental factors, and lifestyle. Genetic polymorphisms significantly affect drug metabolism, efficacy, and toxicity, leading to variations in therapeutic outcomes among patients. Pharmacogenomics helps in reducing adverse drug reactions, improving drug efficacy, and optimizing treatment plans. This review discusses the role of genetic variation in drug response, important pharmacogenomic biomarkers, clinical applications, advantages, challenges, and future prospects of personalized medicine in healthcare.},
        keywords = {Pharmacogenomics, Personalized Medicine, Genetic Variation, Drug Response, CYP450, Precision Medicine, Pharmacogenetics.},
        month = {June},
        }